NOVOS Vital Organ Support has 4 documented interactions in Magellan’s curated dataset, covering Antiplatelet drugs, Anticoagulants (blood thinners), Diabetes medications. Each entry below gives the mechanism as the cited reference states it, the direction the risk runs, how serious that reference treats it, and what to actually do about it — which is, in every case, a conversation with the clinician or pharmacist who manages the prescription rather than a decision you make alone.
What it is. NOVOS Vital is a multi-ingredient gummy supplement marketed for whole-body organ support, combining seven food-derived compounds: lutein and zeaxanthin (xanthophyll carotenoids concentrated in the retina and brain), nattokinase (a fibrinolytic enzyme from fermented soybeans/natto), inulin (a prebiotic fermentable fiber), apple cider vinegar (a source of acetic acid), rutin (a flavonoid), and trehalose (a disaccharide that can induce autophagy). Each ingredient acts through a distinct, well-characterized mechanism rather than a single shared pathway.
Where it sits on the evidence. Magellan grades the supplement itself as Emerging evidence. That grade is about whether it works, not about whether it is safe alongside your medication — the two questions are independent, and this page answers only the second.
Products this covers: NOVOS Vital Organ Support.
How the risks cluster. The entries split across 4 different mechanisms — bleeding risk; both directions at once; drug levels; additive — and they are not managed the same way, so read each one rather than assuming a single rule covers all of them.
Safety and efficacy are separate questions, and this page only answers the first. For the second, the study Magellan’s coverage of NOVOS Vital Organ Support rests on is:
“Meta-analysis of 6 RCTs (n=546) found nattokinase reduced systolic blood pressure by about 3.5 mmHg and diastolic by 2.3 mmHg, with mixed lipid signals at low doses.”
A strong result does not make a supplement safe alongside your prescription, and a documented interaction does not mean the supplement does not work. Magellan grades those two things separately, and neither grade moves for a commission.
Magellan’s Medication Safety Check runs entirely on your device — type the medicines you take and it flags every documented interaction in this dataset. Nothing you type is sent anywhere.
Open the Medication Safety Check →Nattokinase can enhance the antiplatelet effect of aspirin and other antiplatelet drugs, with documented reports of increased bleeding, including intracerebral hemorrhage; contraindicated in people with coagulation disorders or a history of DVT.
Medicines in this group include: Aspirin (Asa, Bayer aspirin), Clopidogrel (Plavix), Ticagrelor (Brilinta), Prasugrel (Effient), Dipyridamole (Aggrenox, Persantine).
Contains nattokinase, a fibrinolytic enzyme; nattokinase increases bleeding risk with anticoagulants and, because the natto fermentation process continues producing vitamin K in the gut, may also reduce warfarin's effectiveness - a combination that makes anticoagulation control unpredictable. Should be stopped before surgery.
Medicines in this group include: Warfarin (Coumadin, Jantoven), Apixaban (Eliquis), Rivaroxaban (Xarelto), Dabigatran (Pradaxa), Edoxaban (Savaysa), Heparin (Lovenox, Enoxaparin), Acenocoumarol (Sintrom), Aspirin (Asa, Bayer aspirin) and 4 more.
Rutin, a bioflavonoid in this blend, may alter warfarin blood levels and effect; more frequent INR monitoring is recommended when combined.
Medicines in this group include: Warfarin (Coumadin, Jantoven), Apixaban (Eliquis), Rivaroxaban (Xarelto), Dabigatran (Pradaxa), Edoxaban (Savaysa), Heparin (Lovenox, Enoxaparin), Acenocoumarol (Sintrom).
Apple cider vinegar can lower fasting and post-meal blood glucose and slow gastric emptying; combined with diabetes medication this could theoretically add to blood-sugar-lowering effects, though evidence is limited.
Medicines in this group include: Metformin (Glucophage, Fortamet), Insulin (Humalog, Novolog), Glipizide (Glucotrol), Glyburide (Diabeta, Glynase), Glimepiride (Amaryl), Sitagliptin (Januvia), Empagliflozin (Jardiance), Dapagliflozin (Farxiga) and 5 more.
These are the warning signs that go with the medication classes on this page. They are general safety-netting, not a prediction that any supplement will cause them.
If something feels seriously wrong, do not wait for an appointment. Call 911 (US) or your local emergency number.
Severity describes the interaction as the cited reference frames it, not how a specific person will react. A “minor” entry in someone with kidney disease, on five other drugs, can matter more than a “major” one in someone on nothing else.
This is a curated set of interactions with citations — not an exhaustive pharmacology database. An interaction that is absent here has not been ruled out; it may simply not be documented in the references Magellan curates from. Supplements are also not batch-tested for identity or contamination the way prescription drugs are, so what is on the label is a claim rather than a guarantee. And most of these entries come from case reports and mechanistic work rather than randomized trials, which is exactly why the sensible response is a pharmacist review rather than either alarm or dismissal.
22 documented interactions across 17 supplements.
9 documented interactions across 9 supplements.
8 documented interactions · shares a drug class with NOVOS Vital Organ Support.
7 documented interactions · shares a drug class with NOVOS Vital Organ Support.
5 documented interactions · shares a drug class with NOVOS Vital Organ Support.
4 documented interactions · shares a drug class with NOVOS Vital Organ Support.
A–Z of every supplement and drug class in this dataset, plus how to read an interaction.
What the research actually shows, graded independently of affiliate commissions.
Not without checking with the prescriber or pharmacist first. Magellan's dataset grades this as a major interaction: Nattokinase can enhance the antiplatelet effect of aspirin and other antiplatelet drugs, with documented reports of increased bleeding, including intracerebral hemorrhage; contraindicated in people with coagulation disorders or a history of DVT. (Source: Nattokinase.)
4 interactions are documented in Magellan's curated dataset: 2 major, 1 moderate, 1 minor. They cover Antiplatelet drugs, Anticoagulants (blood thinners), Diabetes medications. Absence from this list is not proof of safety — it means no interaction is documented in the references we curate from.